Aditi Dutt

Array ( [id] => 152192 [patent_doc_number] => 07678885 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-16 [patent_title] => 'Recombinant bone morphogenetic protein heterodimers, compositions and methods of use' [patent_app_type] => utility [patent_app_number] => 10/375150 [patent_app_country] => US [patent_app_date] => 2003-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 12 [patent_no_of_words] => 19751 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/678/07678885.pdf [firstpage_image] =>[orig_patent_app_number] => 10375150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7382122 [patent_doc_number] => 20040081973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Cloning and characterization of a novel BK channel isoform highly expressed in glioma cells' [patent_app_type] => new [patent_app_number] => 10/375293 [patent_app_country] => US [patent_app_date] => 2003-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14532 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20040081973.pdf [firstpage_image] =>[orig_patent_app_number] => 10375293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7110671 [patent_doc_number] => 20050208126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Chemical ifg-i composition for the treatment and prevention of neurodgenerative diseases' [patent_app_type] => utility [patent_app_number] => 10/505934 [patent_app_country] => US [patent_app_date] => 2003-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4925 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208126.pdf [firstpage_image] =>[orig_patent_app_number] => 10505934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6852006 [patent_doc_number] => 20030144209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Amino -terminal modified parathyroid hormone (PTH) analogs' [patent_app_type] => new [patent_app_number] => 10/361928 [patent_app_country] => US [patent_app_date] => 2003-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15208 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144209.pdf [firstpage_image] =>[orig_patent_app_number] => 10361928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7219843 [patent_doc_number] => 20040072181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Methods for determining drug responsiveness' [patent_app_type] => new [patent_app_number] => 10/348346 [patent_app_country] => US [patent_app_date] => 2003-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15444 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072181.pdf [firstpage_image] =>[orig_patent_app_number] => 10348346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7135990 [patent_doc_number] => 20040043929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Novel proteins and nucleic acids encoding same' [patent_app_type] => new [patent_app_number] => 10/336472 [patent_app_country] => US [patent_app_date] => 2003-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 147177 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043929.pdf [firstpage_image] =>[orig_patent_app_number] => 10336472 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7226738 [patent_doc_number] => 20040072997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Therapeutic polypeptides, nucleic acids encoding same, and methods of use' [patent_app_type] => new [patent_app_number] => 10/336603 [patent_app_country] => US [patent_app_date] => 2003-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 95212 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072997.pdf [firstpage_image] =>[orig_patent_app_number] => 10336603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7230514 [patent_doc_number] => 20050079156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'Method of treating endometreosis' [patent_app_type] => utility [patent_app_number] => 10/494699 [patent_app_country] => US [patent_app_date] => 2002-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 7968 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20050079156.pdf [firstpage_image] =>[orig_patent_app_number] => 10494699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6627666 [patent_doc_number] => 20030211040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Phosphodiesterase activity and regulation of phosphodiesterase 1B-mediated signaling in brain' [patent_app_type] => new [patent_app_number] => 10/233449 [patent_app_country] => US [patent_app_date] => 2002-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 33730 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211040.pdf [firstpage_image] =>[orig_patent_app_number] => 10233449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7234087 [patent_doc_number] => 20050079572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'Organic compounds' [patent_app_type] => utility [patent_app_number] => 10/483915 [patent_app_country] => US [patent_app_date] => 2002-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 22698 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20050079572.pdf [firstpage_image] =>[orig_patent_app_number] => 10483915 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 876820 [patent_doc_number] => 07358340 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-15 [patent_title] => 'PRO19563 antibodies' [patent_app_type] => utility [patent_app_number] => 10/188770 [patent_app_country] => US [patent_app_date] => 2002-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 615 [patent_figures_cnt] => 615 [patent_no_of_words] => 56452 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/358/07358340.pdf [firstpage_image] =>[orig_patent_app_number] => 10188770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6838800 [patent_doc_number] => 20030036140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-20 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/187588 [patent_app_country] => US [patent_app_date] => 2002-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 616 [patent_figures_cnt] => 616 [patent_no_of_words] => 57339 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20030036140.pdf [firstpage_image] =>[orig_patent_app_number] => 10187588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5813026 [patent_doc_number] => 20060083713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Methods of using a human il-17 related polypeptide to treat disease' [patent_app_type] => utility [patent_app_number] => 10/381094 [patent_app_country] => US [patent_app_date] => 2001-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28000 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20060083713.pdf [firstpage_image] =>[orig_patent_app_number] => 10381094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7034172 [patent_doc_number] => 20050032682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Preventives and remedies for diseases in association with demyelination' [patent_app_type] => utility [patent_app_number] => 10/312721 [patent_app_country] => US [patent_app_date] => 2001-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5742 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032682.pdf [firstpage_image] =>[orig_patent_app_number] => 10312721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 575710 [patent_doc_number] => 07459524 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-12-02 [patent_title] => 'Chlamydia protein, sequence and uses thereof' [patent_app_type] => utility [patent_app_number] => 08/942596 [patent_app_country] => US [patent_app_date] => 1997-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20279 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/459/07459524.pdf [firstpage_image] =>[orig_patent_app_number] => 08942596 [rel_patent_id] =>[rel_patent_doc_number] =>)